Professor Janet Hemingway
Liverpool School of Tropical Medicine.
We have evaluated the Excalibur test in our laboratories and found the test to have high analytical sensitivity and specificity. The importance of mass screening for COVID-19 cannot be underestimated, as we saw in the trial in Liverpool which resulted in Liverpool being moved down to Tier 2 in November. Deploying tests, such as this one developed by Excalibur, in populations to screen for asymptomatic infectious subjects will not only help reduce infection but could also produce significant amounts of clinical data which will help in the continuing fight against the virus.
Owner of Ryman and hardware retailer, Robert Dyas, and former judge in Dragon’s Den.
We have bought thousands of Excalibur Rapid Antigen tests and are extremely impressed. We found individuals with no symptoms who showed up as highly infectious and been able to retire these people from mixing with other team members within a matter of minutes of showing positive. These are excellent and invaluable screening tools developed by Excalibur – use them and stay safe.
Acting managing director of Royal Buckinghamshire Hospital.
Our hospital has purchased thousands of Excalibur tests to test staff and visitors across the site. We are using them as the first line of defence as per government guidelines. They have already proved their worth in picking out a number of asymptomatic positive Covid visitors. The tests are very reliable, easy to use and robust. I would highly recommend them in any setting where safety is a concern.
Dr Conal Perrett
Leading UK dermatologist & founder of 18 Week Support, which provides clinicians to support the NHS.
We apply this test every day to every visitor, patient, and staff member without fail. It is very easy to use, produces positive results sometimes within 2-3 minutes and is always extremely reliable and accurate. We have a great confidence in this excellent test and it is relatively inexpensive for what it does.